Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Donanemab: Not two without a third

Kurkinen M.

Adv Clin Exp Med. 2023 Oct;32(10):1085-1087. doi: 10.17219/acem/172673.

Memantine: Updating a rare success story in pro-cognitive therapeutics

Karimi Tari P, Parsons CG, Collingridge GL, Rammes G.

Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11.

Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus

Veselov IM, Vinogradova DV, Maltsev AV, Shevtsov PN, Spirkova EA, Bachurin SO, Shevtsova EF.

Int J Mol Sci. 2023 Sep 22;24(19):14450. doi: 10.3390/ijms241914450.

Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis

Fedele E.

Int J Mol Sci. 2023 Sep 24;24(19):14499. doi: 10.3390/ijms241914499.

Landscape of Phase II Trials in Alzheimer's Disease

Lee A, Shan D, Castle D, Rajji TK, Ma C.

J Alzheimers Dis. 2023;96(2):745-757. doi: 10.3233/JAD-230660.

The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review

Arjmandi-Rad S, Vestergaard Nieland JD, Goozee KG, Vaseghi S.

Neurol Sci. 2024 Feb;45(2):417-430. doi: 10.1007/s10072-023-07114-y. Epub 2023 Oct 16.

Understanding Alzheimer's Disease and its Metal Chelation Therapeutics: A Narrative Review

Thakur R, Karwasra R, Umar T.

Curr Pharm Des. 2023;29(30):2377-2386. doi: 10.2174/0113816128263992231012113847.

Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus

Fauzi A, Thoe ES, Quan TY, Yin ACY.

J Diabetes Complications. 2023 Nov;37(11):108629. doi: 10.1016/j.jdiacomp.2023.108629. Epub 2023 Oct 18.

Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches

Gholami A.

Neurosci Lett. 2023 Nov 20;817:137532. doi: 10.1016/j.neulet.2023.137532. Epub 2023 Oct 20.

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial

Delrieu J, Vellas B, Guyonnet S, Cantet C, Ovod V, Li Y, Bollinger J, Bateman R, Andrieu S; MAPT/DSA group.

Alzheimers Res Ther. 2023 Oct 23;15(1):183. doi: 10.1186/s13195-023-01325-3.

Targeting Endogenous Mechanisms of Brain Resilience for the Treatment and Prevention of Alzheimer's Disease

Shanks HRC, Onuska KM, Massa SM, Schmitz TW, Longo FM.

J Prev Alzheimers Dis. 2023;10(4):699-705. doi: 10.14283/jpad.2023.110.

Reducing the Effects of Ageing on Cognition with Therapeutic Intervention of an Oral Multi-Nutrient: The REACTION Pilot Trial Study Design

Camargo CJ, Merritt S, Modjeski M, Counotte DS, Fernández McInerney K.

J Prev Alzheimers Dis. 2023;10(4):821-827. doi: 10.14283/jpad.2023.81.

Tau-targeting therapies for Alzheimer disease: current status and future directions

Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM.

Nat Rev Neurol. 2023 Dec;19(12):715-736. doi: 10.1038/s41582-023-00883-2. Epub 2023 Oct 24.

The Role of Oxytocin in Alzheimer's Disease and Its Relationship with Social Interaction

Takahashi J, Yamada D, Nagano W, Saitoh A.

Cells. 2023 Oct 10;12(20):2426. doi: 10.3390/cells12202426.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias